Literature DB >> 30232768

Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy.

Massimo Volpe1,2, Allegra Battistoni3, Giovanna Gallo3, Speranza Rubattu3,4, Giuliano Tocci3,4.   

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death, disability and hospitalization in Italy. Primary prevention strategies are able to prevent clinically evident CVDs, mostly by early identifying asymptomatic, otherwise healthy individuals at risk of developing CVDs. A more modern approach recommended for effective CVD prevention is based on "4P", that is: Predictive, Preventive, Personalized and Participative. This executive document reflects the key points of a consensus paper on CV prevention in Italy, realized though the contribution of different Italian Scientific Societies and the National Research Council, and coordinated by the Italian Society of Cardiovascular Prevention (SIPREC), published in 2018. The need for such document relies on the difficulty to apply "sic et simpliciter" European guidelines, to which this document is largely inspired, to national, regional and local realities, in this Mediterranean country, namely Italy. Indeed, our Country has specific features in terms of demography, socio-cultural habits, distribution and prevalence of risk factors, organization, policy and access to National Health Service compared to other European countries.

Entities:  

Keywords:  Cardiovascular mortality; Cardiovascular prevention; Cardiovascular risk factors; Diabetes; Dyslipidaemia; Hypertension; Obesity; Smoking; Vaccination

Mesh:

Substances:

Year:  2018        PMID: 30232768     DOI: 10.1007/s40292-018-0278-8

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  79 in total

1.  [Design and arrangement of the CHIP (CHinese In Prato) study].

Authors:  Pietro Amedeo Modesti; Yang Han; Yang Jing; Wang Xiaoling; Zhang Mengyue; Yang Zihua; Guo Jia; Eleonora Perruolo; Lara Bini; Maira Camera; Annibale Biggeri; Stefano Rapi; Chen Hongsheng; Zhang Li; Wang Zengli; Hu Jianbin; Zhao Xiaoyue; Dong Zhao
Journal:  Epidemiol Prev       Date:  2014 Nov-Dec       Impact factor: 1.901

2.  Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Frank L Greenway; Ken Fujioka; Raymond A Plodkowski; Sunder Mudaliar; Maria Guttadauria; Janelle Erickson; Dennis D Kim; Eduardo Dunayevich
Journal:  Lancet       Date:  2010-07-29       Impact factor: 79.321

3.  Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Rury R Holman; M Angelyn Bethel; Robert J Mentz; Vivian P Thompson; Yuliya Lokhnygina; John B Buse; Juliana C Chan; Jasmine Choi; Stephanie M Gustavson; Nayyar Iqbal; Aldo P Maggioni; Steven P Marso; Peter Öhman; Neha J Pagidipati; Neil Poulter; Ambady Ramachandran; Bernard Zinman; Adrian F Hernandez
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

Review 4.  Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis.

Authors:  Karlijn A C Meeks; Deivisson Freitas-Da-Silva; Adebowale Adeyemo; Erik J A J Beune; Pietro A Modesti; Karien Stronks; Mohammad H Zafarmand; Charles Agyemang
Journal:  Intern Emerg Med       Date:  2015-09-14       Impact factor: 3.397

5.  The risk of myocardial infarction after quitting smoking in men under 55 years of age.

Authors:  L Rosenberg; D W Kaufman; S P Helmrich; S Shapiro
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

Review 6.  American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults.

Authors: 
Journal:  Med Sci Sports Exerc       Date:  1998-06       Impact factor: 5.411

7.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

Review 8.  Evaluation and treatment of older patients with hypercholesterolemia: a clinical review.

Authors:  Timo E Strandberg; Laura Kolehmainen; Alpo Vuorio
Journal:  JAMA       Date:  2014-09-17       Impact factor: 56.272

Review 9.  Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis.

Authors:  Shu Ren; David Newby; Shu Chuen Li; Emily Walkom; Peter Miller; Alexis Hure; John Attia
Journal:  Open Heart       Date:  2015-06-26

Review 10.  Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion.

Authors:  Gilbert P August; Sonia Caprio; Ilene Fennoy; Michael Freemark; Francine R Kaufman; Robert H Lustig; Janet H Silverstein; Phyllis W Speiser; Dennis M Styne; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

View more
  6 in total

1.  Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.

Authors:  Valentina Perrone; Chiara Veronesi; Marco Gambera; Giulio Nati; Francesco Perone; Paola Fausta Tagliabue; Luca Degli Esposti; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-08-28

Review 2.  Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease.

Authors:  Xiao-Ying Li; Li Li; Sang-Hoon Na; Francesca Santilli; Zhongwei Shi; Michael Blaha
Journal:  Am J Prev Cardiol       Date:  2022-06-06

Review 3.  Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.

Authors:  Federico Giulietti; Andrea Filipponi; Giulia Rosettani; Piero Giordano; Corrado Iacoacci; Francesco Spannella; Riccardo Sarzani
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-06-23

Review 4.  Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention.

Authors:  Massimo Volpe; Giovanna Gallo; Maria Grazia Modena; Claudio Ferri; Giovambattista Desideri; Giuliano Tocci
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-01-13

5.  Cardiovascular and Quality of Life Outcomes of a 3-Month Physical Exercise Program in Two Brazilian Communities.

Authors:  Marcelo Pereira de Lima; Severo Conopca; Renata Miyabara; Geovanna Romeiro; Luciana A Campos; Ovidiu C Baltatu
Journal:  Front Med (Lausanne)       Date:  2020-10-20

6.  Effects of Tai Chi Softball Exercises on Physical Fitness Level and Cardiovascular Health-Related Factors among Older Females.

Authors:  XiaoDong Cheng; Yongzhao Fan; Ling Ge; Desen Zang; Jianxi Li; Jian Li; Hao Wu
Journal:  J Healthc Eng       Date:  2021-07-02       Impact factor: 2.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.